자료실

백신실용화기술개발사업단의 관련한 자료를 받을 수 있습니다.

국내외 동향

제목 [글로벌동향] [WHO] WHO guidelines for clinical management of arboviral diseases: dengue, chikungunya, Zika and yellow fever 250704
  • 작성자 관리자
  • 작성일 2025-09-22
  • 조회수 64
첨부파일

Overview

World Health Organization (WHO) has just released the Integrated Guidelines on the Clinical Management of Arboviral Diseases — a crucial step toward strengthening care for the millions of people affected by these viruses each year.

Arboviral diseases, primarily transmitted by Aedes mosquitoes, pose an increasing threat to global health, particularly in the context of climate change, urbanization, and growing human mobility. With over 5.6 billion people worldwide at risk of arboviral infection, it is essential that healthcare professionals have access to evidence-based recommendations to effectively manage these infections in patients.

The new WHO guidelines provide clinical management recommendations for four of the most widespread arboviruses affecting humans: dengue, chikungunya, Zika, and yellow fever.

An integrated approach is vital, as these four diseases often present with similar symptoms, especially in the early stages of infection, and multiple arboviruses may circulate simultaneously in certain regions. This makes clinical differentiation challenging, particularly where diagnostic testing is not readily available.

This guideline is available in online format on the MAGICapp platform here.

 

[출처 : WHO]

이전글 [한국생명기술연구조합] 결핵균 감염 및 질병 예방을 위한 백신개발 파트너십 250916
다음글 [식품의약품안전평가원][생물의약품] 백신의 항체의존 세포포식 및 세포독성 분석 시험정보집 발간 안내 250901